Radiopharm Theranostics Limited
RADX · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $36,437 | – | $18,575 | – |
| Short-Term Investments | $0 | – | $0 | – |
| Receivables | $6,251 | – | $987 | – |
| Inventory | $0 | – | $0 | – |
| Other Curr. Assets | $1,666 | – | $3,286 | – |
| Total Curr. Assets | $44,353 | – | $22,848 | – |
| Property Plant & Equip (Net) | $57 | – | $61 | – |
| Goodwill | $0 | – | $0 | – |
| Intangibles | $6,251 | – | $49,087 | – |
| Long-Term Investments | $40 | – | $40 | – |
| Tax Assets | $0 | – | $0 | – |
| Other NC Assets | $0 | – | $0 | – |
| Total NC Assets | $48,099 | – | $49,188 | – |
| Other Assets | $0 | – | $0 | – |
| Total Assets | $92,452 | – | $72,036 | – |
| Liabilities | – | – | – | – |
| Payables | $3,140 | – | $6,435 | – |
| Short-Term Debt | $0 | – | $0 | – |
| Tax Payable | $0 | – | $0 | – |
| Deferred Revenue | $3,159 | – | $0 | – |
| Other Curr. Liab. | $6,847 | – | $11,141 | – |
| Total Curr. Liab. | $13,146 | – | $17,576 | – |
| LT Debt | $0 | – | $0 | – |
| Deferred Rev, NC | $0 | – | $0 | – |
| Deferred Tax Liab, NC | $0 | – | $0 | – |
| Other NC Liab. | $27,303 | – | $27,107 | – |
| Total NC Liab. | $27,303 | – | $27,107 | – |
| Other Liabilities | $0 | – | $0 | – |
| Cap. Leases | $0 | – | $0 | – |
| Total Liabilities | $40,449 | – | $44,683 | – |
| Equity | – | – | – | – |
| Pref Stock | $0 | – | $0 | – |
| Common Stock | $168,282 | – | $100,682 | – |
| Retained Earnings | -$127,785 | – | -$111,339 | – |
| AOCI | $11,856 | – | $37,930 | – |
| Other Equity | $850 | – | $850 | – |
| Total Equity | $53,202 | – | $28,123 | – |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$1,198 | – | -$769 | – |
| Total Liab. & Tot. Equity | $92,452 | – | $72,036 | – |
| Net Debt | -$36,437 | $0 | -$18,575 | $0 |